| Mammalian
Toxicology |
| Considerable
legislation has been developed to protect people and the environment
from the toxic effects of chemicals. Acute and subchronic toxicity
testing provides fundamental data for evaluating products to inform
both manufacturers and the public of potential hazards. Industries
of significant economic and societal importance depend on safe use
of effective chemicals.
STILLMEADOW,
Inc. takes pride in its ability to provide the toxicology services
needed for premanufacture notifications, registration of pesticides,
labeling and consumer and employee purposes, following USEPA, OECD,
OPPTS, and FDA guidelines.
|
Acute
Studies |
- Acute
Oral Toxicity in Rats Up and Down Method ( OPPTS 870.1100, OECD
425 )
- Traditional
Acute Oral Toxicity in Rats (OPPTS 870.1100, OECD 401)
- Acute
Dermal Toxicity in Rabbits or Rats (OPPTS 870.1200, OECD 402 )
- Acute
Inhalation Toxicity in Rats (OPPTS 870.1300, OECD 403)
- Acute
Eye Irritation in Rabbits (OPPTS 870.2400, OECD 405)
- Acute
Dermal Irritation in Rabbits (OPPTS 870.2500, OECD 404)
- Skin
Sensitization Studies
-Guinea Pig - Buehler Method (OPPTS 870.2600, OECD 429)
-Guinea Pig - Magnusson Kligman Method
-Mouse - Local Lymph Node Assay (OPPTS 870.2600, OECD 429)
|
| Subchronic
Studies |
- 28
and 90-Day Oral Toxicity in Rats or Dogs
- 90
Day Dermal Toxicity in Rats
- 21
and 90-Day Dermal Toxicity in Rabbits
- 28
and 90-Day Inhalation Toxicity in Rats
|
| MPCA
Studies |
- Acute
Oral Toxicity/Infectivity
- Acute
Dermal Toxicity/Irritation
- Pulmonary
Toxicity/Infectivity
- Acute
Injection Toxicity/Infectivity
|
| Preclinical
Development |
| FDA approval of
your Investigational New Drug (IND) application is the result of a
successful preclinical development program, which begins with STILLMEADOW,
Inc.
From guidance
in the creation of unique pilot studies and protocols, to evaluation
of the safety and efficacy of your product, STILLMEADOW Inc.’s
experienced Study Directors and Laboratory Technicians support your
Product Development Team in meeting FDA guidelines for advancement
to clinical trials.
|
- Pharmacokinetic
(PK) analysis of drug absorption, distribution, metabolism and
excretion (ADME)
- Acute
and subchrinic toxicological parameters
- Dose
range-finding studies
- Complete
heamtology and serum chemistry
- Multiple
Species
- Creation
of unique pilot studies and protocols to meet FDA guidelines
|
| STILLMEADOW,
Inc. performs pre-clinical Safety and Efficacy Studies, Pharmacokinetic
Studies, and ADME (Adsorption, Distribution, Metabolism and Excretion)
Studies. Pre
and Post Tox analyses are available in the absence of a Certificate
of Analysis. |
| Entomology
Information - Click here. |
| Send
Inquiries to: justask@stillmeadow.com |